Comparative study of filgrastim and lenograstim for peripheral blood stem cell mobilization in healthy donors

被引：0
|
作者：
De la Rubia, J
Martnez, C
Solano, C
Brunet, S
Arrieta, R
Cascón, P
Alegre, A
Bargay, J
de Arriba, F
Cañizo, C
Zamora, C
Serrano, D
Verdeguer, A
Torrabadella, M
Daz, MA
Insunza, A
de la Serna, J
Espigado, I
Petit, J
Martnez, M
Benlloch, L
Sanz, MA
机构：
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
739
引用
收藏
页码：S219 / S219
页数：1
相关论文
共 50 条
  • [31] Predictive markers for CD34+mobilization in healthy peripheral blood stem cell donors
    Koerper, S.
    Hauber, D.
    Fuerst, D.
    Reinhardt, P.
    Schauweker, P.
    Mytilineos, J.
    Schwarz, K.
    Bunjes, A.
    Wiesneth, M.
    Schrezenmeier, H.
    Oncology Research and Treatment, 2015, 38 : 35 - 36
  • [32] G-CSF (filgrastim) for mobilization of stem cells in healthy donors
    Singhal, S
    Powles, R
    Cabral, S
    Treleaven, J
    Mehta, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 578 - 578
  • [33] PERIPHERAL BLOOD STEM CELL COLLECTION IN HEALTHY DONORS
    Grubovic, R.
    Georgievski, B.
    Cevreska, L.
    Dukovski, R.
    Useini, S.
    Pivkova, A.
    Grubovic, M.
    VOX SANGUINIS, 2013, 105 : 295 - 295
  • [34] Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience
    Martino, Massimo
    Dattola, Antonella
    Fedele, Roberta
    Pontari, Antonella
    Moscato, Tiziana
    Cuzzola, Maria
    Martinello, Tiziana
    BLOOD, 2014, 124 (21)
  • [35] The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey
    Sivgin, Serdar
    Karakus, Esen
    Kaynar, Leylagul
    Kurnaz, Fatih
    Pala, Cigdem
    Keklik, Muzaffer
    Zararsiz, Gokmen
    Solmaz, Musa
    Eser, Bulent
    Cetin, Mustafa
    Unal, Ali
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 48 (03) : 315 - 320
  • [36] Factors affecting peripheral blood stem cells mobilization and collection in healthy donors
    Sancho, E.
    Grifols, J. R.
    Sancho, J. M.
    Ester, A.
    Morgades, M.
    Junca, J.
    Feliu, E.
    Ribera, J-M
    TRANSFUSION, 2008, 48 (02) : 127A - 127A
  • [37] Mobilization of healthy donors with G-CSF for allogenic transplant with peripheral blood stem cell (PBSC)
    Beléndez, C
    Regidor, C
    Sanjuán, I
    Forés, R
    Marcos, M
    Fernández, P
    Lago, M
    Cabrera, R
    Briz, M
    Bañas, H
    Peñalver, FJ
    Barbolla, L
    Fernández, MN
    BONE MARROW TRANSPLANTATION, 1998, 21 : S191 - S191
  • [38] Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience
    Marchesi, Francesco
    Vacca, Michele
    Gumenyuk, Svitlana
    Pandolfi, Annino
    Renzi, Daniela
    Palombi, Francesca
    Pisani, Francesco
    Romano, Atelda
    Spadea, Antonio
    Ipsevich, Francesco
    Santinelli, Susanna
    De Rienzo, Mafalda
    Papa, Elena
    Canfora, Marco
    Laurenzi, Lamberto
    Foddai, Maria Laura
    Pierelli, Luca
    Mengarelli, Andrea
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 489 - 492
  • [39] Filgrastim alone versus chemotherapy plus filgrastim for peripheral blood stem cell mobilization in multiple myeloma.
    Donato, ML
    Chu, DT
    Alexanian, R
    Weber, DM
    Korbling, MJ
    Giralt, SA
    Champlin, RE
    BLOOD, 2000, 96 (11) : 182A - 182A
  • [40] Comparing the effectiveness of biosimilar filgrastim (Nivestim®) versus original filgrastim (Neupogen®) for stem cell mobilization in adult and pediatric healthy donors
    Muffarrej, Duaa
    Hashem, Hasan
    Tbakhi, Abdelghani
    Najjar, Rula
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023,
12345